Clinical trial

ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDD

NCT01381107

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-05-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2011-05-01Date precision: month

Registry last updated2011-08-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderunresolved

Interventions

ALKS 5461DRUG

PlaceboDRUG

Sponsors & collaborators

Alkermes, Inc.lead sponsor

Mapped research locations

AtlantaGeorgia, United States1 St. PetersburgFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01381107 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.